Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma

BACKGROUND: Thymoma and thymic carcinoma are rare thymic epithelial tumors. We investigated the efficacy of first‐line gemcitabine and cisplatin (GP) chemotherapy versus gemcitabine and cisplatin chemotherapy combined with the anti‐angiogenic drug endostar (GP + E) in advanced thymoma and thymic car...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Nie, Jun, Dai, Ling, Hu, Weiheng, Chen, Xiaoling, Han, Jindi, Ma, Xiangjuan, Tian, Guangming, Han, Sen, Long, Jieran, Zhang, Ziran, Fang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312837/
https://www.ncbi.nlm.nih.gov/pubmed/30411854
http://dx.doi.org/10.1111/1759-7714.12891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312837/
https://www.ncbi.nlm.nih.gov/pubmed/30411854
http://dx.doi.org/10.1111/1759-7714.12891

Ejemplares similares